Céline S Gonçalves

11PUBLICATIONS
31CO-AUTHORS
Cancer cell biologyMedical biochemistry - carbohydratesPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 11, 2025
Functional and Mechanistic Insights of 3-Hydroxybutyrate (3-OBA) in Bladder Cancer.

Ana Silva, Ana Mafalda Félix, Céline S Gonçalves

|Dec 23, 2023
Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer.

Ana Silva, Ana Félix, Mónica Cerqueira

|Feb 11, 2023
Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.

Julieta Afonso, Céline Gonçalves, Marta Costa

|Jan 22, 2022
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.

Cláudia Martins-Lima, Vera Miranda-Gonçalves, João Lobo

|Dec 17, 2021
Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.

Eduarda P Martins, Céline S Gonçalves, Marta Pojo

|Jul 24, 2021
MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma.

Vera Miranda-Gonçalves, Céline S Gonçalves, Sara Granja

Pageof 2

Frequent Collaborators

8 joint publications

Bruno M Costa

5 joint publications

Fátima Baltazar

4 joint publications

Adhemar Longatto-Filho

3 joint publications

Julieta Afonso